BARD markets its products and services worldwide to hospitals, individual health care professionals, extended care facilities, and alternate site facilities.
BARD pioneered the development of single-patient-use medical products for hospital procedures; today BARD is dedicated to pursuing technological innovations that offer superior clinical benefits while helping to reduce overall costs.
BARD,s core values of Quality, Integrity, Service, and Innovation represent our reality and our aspirations. These four values prepare us for the challenges ahead and guide our everyday activities and align us to our mission. They are central to how we behave and want to be viewed by our fellow co-workers, customers, shareholders and communities.
BioVentrix is a privately held medical device company headquartered in San Ramon, CA, USA. Their mission is to improve and expand the treatment available of congestive heart failure (CHF) caused by ischemic cardiomyopathy, through the development of less invasive, catheter-based approaches.
Vascular Innovations Co. Ltd is a design, development and manufacturing company focused on the congenital and structural heart disease market. The primary focus is to design products that facilitate the correction of defects in the heart. These defects include malformations, degreneration of structures and/or mechanical defects.